These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23967183)

  • 1. Serum MMP-8: a novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction.
    Fertin M; Lemesle G; Turkieh A; Beseme O; Chwastyniak M; Amouyel P; Bauters C; Pinet F
    PLoS One; 2013; 8(8):e71280. PubMed ID: 23967183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling.
    Webb CS; Bonnema DD; Ahmed SH; Leonardi AH; McClure CD; Clark LL; Stroud RE; Corn WC; Finklea L; Zile MR; Spinale FG
    Circulation; 2006 Sep; 114(10):1020-7. PubMed ID: 16923753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.
    Purcell BP; Barlow SC; Perreault PE; Freeburg L; Doviak H; Jacobs J; Hoenes A; Zellars KN; Khakoo AY; Lee T; Burdick JA; Spinale FG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H814-H825. PubMed ID: 29979624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular matrix turnover biomarkers predict long-term left ventricular remodeling after myocardial infarction: insights from the REVE-2 study.
    Eschalier R; Fertin M; Fay R; Bauters C; Zannad F; Pinet F; Rossignol P
    Circ Heart Fail; 2013 Nov; 6(6):1199-205. PubMed ID: 23983248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of serial assessment of B-type natriuretic peptide, troponin I, and C-reactive protein to predict left ventricular remodeling after acute myocardial infarction (from the REVE-2 study).
    Fertin M; Hennache B; Hamon M; Ennezat PV; Biausque F; Elkohen M; Nugue O; Tricot O; Lamblin N; Pinet F; Bauters C
    Am J Cardiol; 2010 Nov; 106(10):1410-6. PubMed ID: 21059429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition.
    Ikonomidis JS; Hendrick JW; Parkhurst AM; Herron AR; Escobar PG; Dowdy KB; Stroud RE; Hapke E; Zile MR; Spinale FG
    Am J Physiol Heart Circ Physiol; 2005 Jan; 288(1):H149-58. PubMed ID: 15598866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction.
    Kelly D; Khan SQ; Thompson M; Cockerill G; Ng LL; Samani N; Squire IB
    Eur Heart J; 2008 Sep; 29(17):2116-24. PubMed ID: 18614523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible mechanism by which renal sympathetic denervation improves left ventricular remodelling after myocardial infarction.
    Zheng XX; Li XY; Lyu YN; He YY; Wan WG; Zhu HL; Jiang XJ
    Exp Physiol; 2016 Feb; 101(2):260-71. PubMed ID: 26556551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of soluble Fas ligand and left ventricular remodeling after acute myocardial infarction (from the REVE-2 study).
    Fertin M; Bauters A; Pinet F; Bauters C
    J Cardiol; 2012 Aug; 60(2):93-7. PubMed ID: 22521430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.
    Hudson MP; Armstrong PW; Ruzyllo W; Brum J; Cusmano L; Krzeski P; Lyon R; Quinones M; Theroux P; Sydlowski D; Kim HE; Garcia MJ; Jaber WA; Weaver WD
    J Am Coll Cardiol; 2006 Jul; 48(1):15-20. PubMed ID: 16814643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
    Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
    J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
    Peterson JT; Li H; Dillon L; Bryant JW
    Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metalloproteinases-2 and -9 predict left ventricular remodeling after myocardial infarction.
    Cogni AL; Farah E; Minicucci MF; Azevedo PS; Okoshi K; Matsubara BB; Zanati S; Haggeman R; Paiva SA; Zornoff LA
    Arq Bras Cardiol; 2013 Apr; 100(4):315-21. PubMed ID: 23525272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted regional injection of biocomposite microspheres alters post-myocardial infarction remodeling and matrix proteolytic pathways.
    Dixon JA; Gorman RC; Stroud RE; Mukherjee R; Meyer EC; Baker NL; Morita M; Hamamoto H; Ryan LP; Gorman JH; Spinale FG
    Circulation; 2011 Sep; 124(11 Suppl):S35-45. PubMed ID: 21911817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study.
    Hansson J; Lind L; Hulthe J; Sundström J
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):297-303. PubMed ID: 19387352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
    Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted overexpression of tissue inhibitor of matrix metalloproteinase-4 modifies post-myocardial infarction remodeling in mice.
    Zavadzkas JA; Stroud RE; Bouges S; Mukherjee R; Jones JR; Patel RK; McDermott PJ; Spinale FG
    Circ Res; 2014 Apr; 114(9):1435-45. PubMed ID: 24637197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating miR-133a and miR-423-5p fail as biomarkers for left ventricular remodeling after myocardial infarction.
    Bauters C; Kumarswamy R; Holzmann A; Bretthauer J; Anker SD; Pinet F; Thum T
    Int J Cardiol; 2013 Oct; 168(3):1837-40. PubMed ID: 23347612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracoronary delivery of recombinant TIMP-3 after myocardial infarction: effects on myocardial remodeling and function.
    Barlow SC; Doviak H; Jacobs J; Freeburg LA; Perreault PE; Zellars KN; Moreau K; Villacreses CF; Smith S; Khakoo AY; Lee T; Spinale FG
    Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H690-H699. PubMed ID: 28754718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.